UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038690
Receipt number R000044099
Scientific Title Non-invasive AI wearable device for supporting medical care
Date of disclosure of the study information 2019/11/25
Last modified on 2019/11/25 19:46:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Non-invasive AI wearable device for supporting medical care

Acronym

Non-invasive AI wearable device for supporting medical care

Scientific Title

Non-invasive AI wearable device for supporting medical care

Scientific Title:Acronym

AI-supported medical care

Region

Japan


Condition

Condition

Epilepsy, Parkinson Disease, Cerebrovascular disease, Spinal cord injury, idiopathic normal pressure hydrocephalus, spastic paralysis

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Development of AI system to predict unexpected events in various neurological diseases based on clinical data acquired simultaneously using non-invasive wearable device.

Basic objectives2

Others

Basic objectives -Others

prediction of unexpected events in various neurological diseases

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relationship between clinical data and data acquired simultaneously using non-invasive wearable device

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Subjects included in this study must fulfill one of the following criteria:
1. diagnosed with Parkinson Disease or its related disease (40 to 85 years old)
2. has motor dysfunction due to cerebrovascular disease (12 years old onwards)
3. diagnosed with epilepsy (12 years old onwards)
4. diagnosed with spinal cord injury (12 years old onwards)
5. diagnosed with idiopathic normal pressure hydrocephalus (12 years old onwards)
6. diagnosed with spastic paralysis (12 years old onwards)

Key exclusion criteria

Subjects who fulfill any of the following criteria will be excluded from this study.
1. Individuals with severe intellectual disability in whom proper communication is not possible and thus wearing the wearable device deemed impossible.
2. Individuals considered incompetent to participate in this study by the attending physician.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Haruhiko
Middle name
Last name Kishima

Organization

Osaka University Graduate School of Medicine

Division name

Neurosurgery

Zip code

565-0871

Address

2-2, Yamadaoka, Suita, Japan.

TEL

06-6879-3652

Email

hkishima@nsurg.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Hui Ming
Middle name
Last name Khoo

Organization

Osaka University Graduate School of Medicine

Division name

Neurosurgery

Zip code

565-0871

Address

2-2, Yamadaoka, Suita, Japan.

TEL

06-6879-3652

Homepage URL


Email

khoo@nsurg.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University

Institute

Department

Personal name



Funding Source

Organization

Cabinet Office (Japan)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Clinical Research Review Committee

Address

2-2, Yamadaoka, Suita

Tel

06-6210-8289

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 11 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 04 Month 24 Day

Date of IRB

2019 Year 10 Month 24 Day

Anticipated trial start date

2019 Year 10 Month 24 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Non-randomized non-blinded prospective case series study


Management information

Registered date

2019 Year 11 Month 25 Day

Last modified on

2019 Year 11 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044099


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name